Cassandre Coyer

Washington, D.C., United States

Privacy reporter for @BLaw. Formerly @Legaltech_news @mcclatchy @csmonitor. Retweets ≠ endorsement - Get in touch: [email protected] 🇫🇷🧀

Featured in: Favicon

law.com

yahoo.com (+3) Favicon

chicagotribune.com Favicon

csmonitor.com Favicon

flipboard.com Favicon

seattletimes.com Favicon

startribune.com Favicon

miamiherald.com Favicon

thestar.com.my Favicon

madison.com + 93 more

Articles

23andMe Co-Founder’s Bankruptcy Sale Fight Prompts Objections

1 week ago | news.bloomberglaw.com | James Nani |Cassandre Coyer

23andMe committee is evaluating co-founder’s latest bidRegeneron, as buyer, seeks to avoid delay, narrow discoveryRegeneron Pharmaceuticals and a privacy ombudsman are raising concerns over a push by 23andMe’s co-founder to challenge the drug developer’s $256 million bid for the bankrupt genetic-testing firm’s DNA data bank.
23andMe’s Genetic Data Trove Rests on Professor as Protector (1)

2 weeks ago | news.bloombergtax.com | Cassandre Coyer |Catalina Camia |Jeff Harrington |David Jolly

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor. The May 19 announcement that Regeneron Pharmaceuticals Inc. will buy most of the assets of the bankrupt genetic testing provider started a countdown for Washington University School of Law professor Neil Richards, the court-appointed privacy ombudsman, to investigate the company’s privacy policies.
23andMe’s Genetic Data Trove Rests on Professor as Protector

2 weeks ago | news.bloomberglaw.com | Cassandre Coyer

Privacy ombudsman Neil Richards breaks with traditionOmbudsman’s report can shape data sale amid privacy concernsA crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor. The May 19 announcement that Regeneron Pharmaceuticals Inc.
Rite Aid Sale of Customer Health Data Looms as Security Concern

3 weeks ago | news.bloomberglaw.com | Cassandre Coyer

The pending sale of millions of customer health records as part of ‘s bankruptcy proceedings is putting a spotlight on data security protections as the health-care industry battles increasing cyber incidents. The pharmacy chain filed May 5 for Chapter 11 protection, less than a year since it exited its first bankruptcy in August 2024. A rival pharmacy is expected to acquire its most valuable assets: customers’ prescription information.
Rite Aid Sale of Customer Health Data Looms as Security Concern

3 weeks ago | news.bloombergtax.com | Cassandre Coyer |Jeff Harrington |David Jolly

The pending sale of millions of customer health records as part of Rite Aid Corp.‘s bankruptcy proceedings is putting a spotlight on data security protections as the health-care industry battles increasing cyber incidents. The pharmacy chain filed May 5 for Chapter 11 protection, less than a year since it exited its first bankruptcy in August 2024. A rival pharmacy is expected to acquire its most valuable assets: customers’ prescription information.
23andMe Customers Must File Claims Over 2023 Breach Before July

3 weeks ago | news.bloomberglaw.com | Cassandre Coyer

Customers whose personal information was exposed during genetic-testing firm 23andMe Holding Co.'s 2023 data breach can file claims to seek financial compensation as part of the company’s bankruptcy proceedings, according to an alert sent by the company Friday. 23andMe and its subsidiaries filed for Chapter 11 bankruptcy in March after it was unable to find a buyer to rescue it from insolvency proceedings.
Brain Data Companies Brace for Patchwork of Privacy Regulations

3 weeks ago | news.bloombergtax.com | Cassandre Coyer |Jeff Harrington |David Jolly

Health gadgets and medical devices that track brainwaves—and the companies that make them—are at the core of a next-level debate over privacy protections. State and federal lawmakers worried about data misuse, manipulation, and even “brain-control weaponry” want to restrict how neurotechnology companies ranging from Elon Musk‘s NeuroLink Ltd. to makers of brain-health wearables collect and use brain-related data.
California Privacy Penalties Focus on Quality Checks, Web Design

1 month ago | news.bloombergtax.com | Cassandre Coyer

The California Privacy Protection Agency’s second enforcement action under the state’s privacy law signals that companies’ execution of consumer rights requests is at the center of the regulator’s priorities. The CPPA—the only state privacy regulator of its kind in the US—on Tuesday hit Todd Snyder Inc. with a $345,178 fine for violating the California Consumer Privacy Act. It ordered the clothing retailer, owned by American Eagle Outfitters Inc., to change its privacy practices within 90 days.
AI Leaders Find Even Talking About Privacy Concerns a Struggle

1 month ago | news.bloomberglaw.com | Cassandre Coyer |Kaustuv Basu

All eyes turned to Sam Altman. It had been days of workshops and panels at IAPP’s privacy summit, where professionals talk about managing personal information responsibly. Now, Altman, the CEO of OpenAI Inc. was asked: “What does privacy mean to you? Can I ask you that? What do you think privacy means?”Altman, who was attending virtually, hesitated briefly as he loomed over the audience from a giant video screen at Washington’s convention center.
New York’s Latest Cyber Rules Pressure Small Companies, Vendors

1 month ago | news.bloomberglaw.com | Cassandre Coyer

As another cybersecurity compliance deadline hits in New York, the impact may be most deeply felt by smaller companies—as well as vendors and other businesses outside the financial sector that technically aren’t within scope of the regulation. The New York Department of Financial Services’ (NYDFS) latest Cybersecurity Regulation amendments go into effect Thursday for financial, banking, and insurance entities, and they’re among the most technical and granular requirements yet.